ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1194

A Module on Large Vessel Vasculitis for Learners in Rheumatology

David Shoemaker1, Stamatina Danielides1, Abhishek Nandan1, Huzaefah Syed2, Beth Rubinstein1 and Seema Patel1, 1Virginia Commonwealth University, Richmond, VA, 2Virginia Commonwealth University Medical Center, Richmond, VA

Meeting: ACR Convergence 2021

Keywords: Education, education, medical, giant cell arteritis, Takayasu.s arteritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Professional Education Poster (1170–1195)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Of the rheumatic disorders that learners are expected to know, the vasculitides are among the hardest to grasp. Their pathogenesis is not well-established, they have many overlapping clinical features and they are rarely encountered in general medical practice. Additionally, the consequences of missed diagnosis and delayed treatment can be catastrophic. Therefore, “vasculitis” is a frequently requested topic for teaching from rotating learners. There also have been important advancements in diagnostic methods, guidelines and available treatments that our rotating learners should know about but may not yet have encountered in training.

This module focused on large vessel vasculitis (LVV), namely giant cell arteritis (GCA) and Takayasu arteritis (TAK). It is part of a larger module-based Rheumatology curriculum undergoing development at Virginia Commonwealth University School of Medicine (VCU SOM). The primary goal of this module is to provide learners with a short, effective learning tool to improve their understanding of the clinical features, diagnostic methods and treatment options of LVV in preparation for the cases they may encounter on tests and in clinical practice.

Methods: The study was conducted at VCU SOM. A brief slide-based topic overview was created using Apple Keynote that succinctly covered GCA and TAK. Slides contained high yield characteristics of the background, presentation, exam findings, diagnosis and treatment of these disorders. A test was created and administered for self-assessment and data collection via a secure online, cloud-based program. The test included 10 multiple choice questions to assess knowledge of the clinical presentations, preferred diagnostic techniques and treatment for LVV. A brief topic comfort survey was also created to compare the learner’s confidence in the material before and after the module. Learners rated their confidence in three domains on a scale 1-100 (clinical features, exam findings, diagnostic modalities). Learners were asked to take the test and survey just prior to proceeding with the topic overview and again upon completion of the content. Data were analyzed using the unpaired t-test.

Results: Seven participants completed the module. Learners reported a greater degree of confidence after completing the module compared to baseline (mean topic comfort scores of 78.1 and 48.4, respectively; improvement of 29.7 points, 16.9 — 42.5, p = 0.0003). This corresponded with significant improvement in test performance—mean pretest score was 57.1%, compared with mean posttest score of 98.6% (improvement of 41.5%, 29.6% — 53.2%, p = < 0.0001).

Conclusion: While sample size was small, the results show that this module helped learners significantly improve confidence in their knowledge of large vessel vasculitis, which corresponded with significant improvement in test score performance. Plans for future study involve testing participants again after one month to assess the durability of these effects.

Results of each participant’s topic comfort rating before and after completing the educational content.

Results of each participant’s test scores before and after completing the educational content.


Disclosures: D. Shoemaker, None; S. Danielides, None; A. Nandan, None; H. Syed, None; B. Rubinstein, None; S. Patel, None.

To cite this abstract in AMA style:

Shoemaker D, Danielides S, Nandan A, Syed H, Rubinstein B, Patel S. A Module on Large Vessel Vasculitis for Learners in Rheumatology [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/a-module-on-large-vessel-vasculitis-for-learners-in-rheumatology/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-module-on-large-vessel-vasculitis-for-learners-in-rheumatology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology